| 出版应用/物种/样本/稀释 | 参考文献 |
|---|
- 免疫组化-石蜡切片; 人类; 1:100; 图 6A
| Celiku O, Tandle A, Chung J, Hewitt S, Camphausen K, Shankavaram U. Computational analysis of the mesenchymal signature landscape in gliomas. BMC Med Genomics. 2017;10:13 pubmed 出版商 |
- 免疫组化-石蜡切片; 人类; 1:100; 图 2e
| Morrow C, Trapani F, Metcalf R, Bertolini G, Hodgkinson C, Khandelwal G, et al. Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study. Ann Oncol. 2016;27:1155-60 pubmed 出版商 |
- 免疫组化-石蜡切片; 人类; 1:150; 图 1
| Schirosi L, De Summa S, Tommasi S, Paradiso A, Sambiasi D, Popescu O, et al. Immunoprofile from tissue microarrays to stratify familial breast cancer patients. Oncotarget. 2015;6:27865-79 pubmed 出版商 |
| Oon M, Thike A, Tan S, Tan P. Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast. Breast Cancer Res Treat. 2015;150:31-41 pubmed 出版商 |
| Heo J, Noh B, Lee S, Lee H, Kim Y, Lim J, et al. Phosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesis. EMBO Mol Med. 2019;:e10880 pubmed 出版商 |
| Libard S, Popova S, Amini R, Kärjä V, Pietiläinen T, Hämäläinen K, et al. Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or grade. PLoS ONE. 2014;9:e108861 pubmed 出版商 |
| Pitule P, Cedíková M, Daum O, Vojtisek J, Vycital O, Hosek P, et al. Immunohistochemical detection of cancer stem cell related markers CD44 and CD133 in metastatic colorectal cancer patients. Biomed Res Int. 2014;2014:432139 pubmed 出版商 |
| Hou Y, Chao Y, Tung H, Wang H, Shan Y. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma. Cancer. 2014;120:2766-77 pubmed 出版商 |
